Genotype-phenotype correlation in Becker muscular dystrophy in Chinese patients

被引:7
作者
Yuan, Ruiyi [1 ,2 ]
Yi, Junfei [1 ]
Xie, Zhiying [1 ]
Zheng, Yimeng [1 ]
Han, Miao [3 ]
Hou, Yue [4 ]
Wang, Zhaoxia [1 ]
Yuan, Yun [1 ]
机构
[1] Peking Univ, Hosp 1, Dept Neurol, Beijing 100034, Peoples R China
[2] Haverford Coll, Haverford, PA 19041 USA
[3] Henan Univ, Hosp 1, Dept Neurol, Kaifeng, Peoples R China
[4] Guangzhou Univ, Tradit Med Hosp, Dept Neurol, Guangzhou, Guangdong, Peoples R China
关键词
EXON-SKIPPING THERAPY; DILATED CARDIOMYOPATHY; HOT-SPOT; DUCHENNE; GENE; PROTEIN; MUTATION; DATABASE; DYSTROPHINOPATHY; VARIABILITY;
D O I
10.1038/s10038-018-0480-5
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Large deletions and duplications are the most frequent causative mutations in Becker muscular dystrophy (BMD), but genetic profile varied greatly among reports. We performed a comprehensive molecular investigation in 95 Chinese BMD patients. All patients were divided into three subtypes: normal muscle strength (type 1) in 18 cases, quadriceps myopathy (type 2) in 20 cases, and limb-girdle weakness (type 3) in 57 cases. Nineteen cases (20.0%) had small mutations and 76 cases (80.0%) had major rearrangements, including 67 cases (70.5%) of exonic deletions and 9 cases (9.5%) of exonic duplications. We identified 50 cases (65.8%) of in-frame mutations, and 26 cases (34.2%) of frame-shift mutations. The frequency of deletion in exons 13-19 was 30.6% in type 1 patients, 9.7% in type 2 patients, and 10.4% in type 3 patients. The frequency of deletion in exons 45-55 was 28.6% in type 1 patients, 40.8% in type 2, and 50.0% in type 3 patients. All major rearrangements of DMD gene in type 1 patients were also observed in type 3 patients. Our study suggested that frame-shift mutation was not rare in Chinese BMD patients. Although no difference was observed on the forms of DMD gene mutations among the three types of patients, the mutation in proximal region of DMD gene has higher frequency for patients without weakness. Effect of exon skipping for DMD depends on the size and location of the mutation. Additional studies are required to determine whether exon-skipping strategies in proximal region of DMD gene could yield more functional dystrophin.
引用
收藏
页码:1041 / 1048
页数:8
相关论文
共 35 条
[1]   Skipping Multiple Exons to Treat DMD-Promises and Challenges [J].
Aslesh, Tejal ;
Maruyama, Rika ;
Yokota, Toshifumi .
BIOMEDICINES, 2018, 6 (01)
[2]  
Basumatary LJ, 2012, J NEUROSCI RURAL PRA, V3, P224, DOI [10.4103/0976-3147.98264, 10.4103/0976-3147.112777]
[3]  
BEGGS AH, 1991, AM J HUM GENET, V49, P54
[4]  
Bello Luca, 2016, Acta Myol, V35, P122
[5]   Functional changes in Becker muscular dystrophy: implications for clinical trials in dystrophinopathies [J].
Bello, Luca ;
Campadello, Paola ;
Barp, Andrea ;
Fanin, Marina ;
Semplicini, Claudio ;
Soraru, Gianni ;
Caumo, Luca ;
Calore, Chiara ;
Angelini, Corrado ;
Pegoraro, Elena .
SCIENTIFIC REPORTS, 2016, 6
[6]   The TREAT-NMD DMD Global Database: Analysis of More than 7,000 Duchenne Muscular Dystrophy Mutations [J].
Bladen, Catherine L. ;
Salgado, David ;
Monges, Soledad ;
Foncuberta, Maria E. ;
Kekou, Kyriaki ;
Kosma, Konstantina ;
Dawkins, Hugh ;
Lamont, Leanne ;
Roy, Anna J. ;
Chamova, Teodora ;
Guergueltcheva, Velina ;
Chan, Sophelia ;
Korngut, Lawrence ;
Campbell, Craig ;
Dai, Yi ;
Wang, Jen ;
Barisic, Nina ;
Brabec, Petr ;
Lahdetie, Jaana ;
Walter, Maggie C. ;
Schreiber-Katz, Olivia ;
Karcagi, Veronika ;
Garami, Marta ;
Viswanathan, Venkatarman ;
Bayat, Farhad ;
Buccella, Filippo ;
Kimura, En ;
Koeks, Zaida ;
van den Bergen, Janneke C. ;
Rodrigues, Miriam ;
Roxburgh, Richard ;
Lusakowska, Anna ;
Kostera-Pruszczyk, Anna ;
Zimowski, Janusz ;
Santos, Rosario ;
Neagu, Elena ;
Artemieva, Svetlana ;
Rasic, Vedrana Milic ;
Vojinovic, Dina ;
Posada, Manuel ;
Bloetzer, Clemens ;
Jeannet, Pierre-Yves ;
Joncourt, Franziska ;
Diaz-Manera, Jordi ;
Gallardo, Eduard ;
Karaduman, A. Ayse ;
Topaloglu, Haluk ;
El Sherif, Rasha ;
Stringer, Angela ;
Shatillo, Andriy V. .
HUMAN MUTATION, 2015, 36 (04) :395-402
[7]   BECKER-TYPE MUSCULAR-DYSTROPHY [J].
BRADLEY, WG ;
JONES, MZ ;
MUSSINI, JM ;
FAWCETT, PRW .
MUSCLE & NERVE, 1978, 1 (02) :111-132
[8]   Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management [J].
Bushby, Katharine ;
Finkel, Richard ;
Birnkrant, David J. ;
Case, Laura E. ;
Clemens, Paula R. ;
Cripe, Linda ;
Kaul, Ajay ;
Kinnett, Kathi ;
McDonald, Craig ;
Pandya, Shree ;
Poysky, James ;
Shapiro, Frederic ;
Tomezsko, Jean ;
Constantin, Carolyn .
LANCET NEUROLOGY, 2010, 9 (01) :77-93
[9]   THE CLINICAL, GENETIC AND DYSTROPHIN CHARACTERISTICS OF BECKER MUSCULAR-DYSTROPHY .2. CORRELATION OF PHENOTYPE WITH GENETIC AND PROTEIN ABNORMALITIES [J].
BUSHBY, KMD ;
GARDNERMEDWIN, D ;
NICHOLSON, LVB ;
JOHNSON, MA ;
HAGGERTY, ID ;
CLEGHORN, NJ ;
HARRIS, JB ;
BHATTACHARYA, SS .
JOURNAL OF NEUROLOGY, 1993, 240 (02) :105-112
[10]   CLINICAL VARIABILITY IN BECKER MUSCULAR-DYSTROPHY - GENETIC, BIOCHEMICAL AND IMMUNOHISTOCHEMICAL CORRELATES [J].
COMI, GP ;
PRELLE, A ;
BRESOLIN, N ;
MOGGIO, M ;
BARDONI, A ;
GALLANTI, A ;
VITA, G ;
TOSCANO, A ;
FERRO, MT ;
BORDONI, A ;
FORTUNATO, F ;
CISCATO, P ;
FELISARI, G ;
TEDESCHI, S ;
CASTELLI, E ;
GARGHENTINO, R ;
TURCONI, A ;
FRASCHINI, P ;
MARCHI, E ;
NEGRETTO, GG ;
ADOBBATI, L ;
MEOLA, G ;
TONIN, P ;
PAPADIMITRIOU, A ;
SCARLATO, G .
BRAIN, 1994, 117 :1-14